These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. NF-κB and androgen receptor variant expression correlate with human BPH progression. Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083 [TBL] [Abstract][Full Text] [Related]
5. NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants. Morel KL; Hamid AA; Clohessy JG; Pandell N; Ellis L; Sweeney CJ Mol Cancer Res; 2021 Jul; 19(7):1137-1145. PubMed ID: 33863813 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor dampens tissue factor expression via nuclear factor-κB and early growth response protein 1. Hoesel B; Mussbacher M; Dikorman B; Salzmann M; Assinger A; Hell L; Thaler J; Basílio J; Moser B; Resch U; Paar H; Mackman N; Schmid JA J Thromb Haemost; 2018 Apr; 16(4):749-758. PubMed ID: 29427323 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer. Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Eto M Endocr Relat Cancer; 2017 Apr; 24(4):171-180. PubMed ID: 28223364 [TBL] [Abstract][Full Text] [Related]
9. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha. Ko S; Shi L; Kim S; Song CS; Chatterjee B Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021 [TBL] [Abstract][Full Text] [Related]
10. The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling. Lamb LE; Zarif JC; Miranti CK Cancer Res; 2011 Apr; 71(7):2739-49. PubMed ID: 21310825 [TBL] [Abstract][Full Text] [Related]
11. Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy. Liu VWS; Yau WL; Tam CW; Yao KM; Shiu SYW Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561752 [TBL] [Abstract][Full Text] [Related]
12. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501 [TBL] [Abstract][Full Text] [Related]
13. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. Lee SO; Lou W; Nadiminty N; Lin X; Gao AC Prostate; 2005 Jul; 64(2):160-7. PubMed ID: 15678501 [TBL] [Abstract][Full Text] [Related]
14. NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Austin DC; Strand DW; Love HL; Franco OE; Grabowska MM; Miller NL; Hameed O; Clark PE; Matusik RJ; Jin RJ; Hayward SW Prostate; 2016 Aug; 76(11):1004-18. PubMed ID: 27197599 [TBL] [Abstract][Full Text] [Related]
15. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells. Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080 [TBL] [Abstract][Full Text] [Related]
16. Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer. McCarty MF; Hejazi J; Rastmanesh R Integr Cancer Ther; 2014 Sep; 13(5):386-95. PubMed ID: 24867960 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
18. Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells. Lee SH; Johnson D; Luong R; Sun Z J Biol Chem; 2015 Jan; 290(5):2759-68. PubMed ID: 25527506 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295 [TBL] [Abstract][Full Text] [Related]
20. NF-κB signaling promotes castration-resistant prostate cancer initiation and progression. Thomas-Jardin SE; Dahl H; Nawas AF; Bautista M; Delk NA Pharmacol Ther; 2020 Jul; 211():107538. PubMed ID: 32201312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]